Morningstar, Inc.

▲ Bull Case

• ◆Wide-moat compounder mispriced by 47%: at 8.8x FY2026E EV/EBITDA vs. peer median ~21x, trades at deepest discount to MCO/SPGI/MSCI/FDS/VRSK in over a decade despite operating margins inflecting from 11.3% (FY2023) to 27.7% (Q1'26) and FCF margin sustaining at 18%. Empirical >100% renewal rates and $1.7B RPO backlog disprove AI-commoditization thesis the multiple implies.
• ◆Founder-aligned capital allocation at scale: Mansueto-approved $1.1B+ trailing-12-month buyback (at avg price well above $180) is strongest possible insider conviction signal. PitchBook (acquired $225M, now $671.8M revenue) was A+ capital decision; standalone value ~$5.2B at 25x EBITDA approaches current consolidated EV ($7.4B). DBRS intangibles amortizing 2028–2030 will add ~$1.15/share to GAAP EPS with no underlying business change.
• ◆Vanguard + DBRS structural revenue legs: Vanguard rebrand of $3T+ AUM from CRSP to Morningstar Indexes is multi-year high-margin royalty stream; conservative 0.25–1.0 bp fee adds $7.5–30M annual run-rate. DBRS +38.4% Q1'26 organic growth on structured-finance issuance + European covered bonds suggests market share gains, not temporary wave. Each is discrete, low-correlation revenue catalyst layered on base subscription growth.

▼ Bear Case

• ◆PitchBook deceleration is flashing warning: Q1 2026 organic growth +0.1% (essentially flat), well below FY2025's +8.5%. If FactSet pricing pressure + Preqin/MSCI competition + AI-driven workflow disruption cause measurable client churn, renewal rates could drift from 103% to 98% within 18 months, removing central pillar of bull case. Market may be right that growth has structurally re-rated from 10–12% to 5–7%.
• ◆DBRS exceptional growth is cyclical: +20.9% FY2025 and +38.4% Q1 2026 reflect peak structured-finance cycle. In 2008–2009, ratings-agency revenue fell 20–40%. With 60.8% of DBRS tied to structured finance (CLOs, CMBS, RMBS), credit-market correction would compress Credit segment revenue 20–25%, eliminating major source of consolidated growth. AUM-correlated Wealth/Retirement revenue (~14% of total) would amplify downside in equity selloff.
• ◆ROIC and quality remain peer-discounted for reasons: MORN ROIC of 15% sits at bottom of peer set (MSCI ~50%, MCO ~35%, SPGI ~20%, FDS ~15%), reflecting heavy DBRS goodwill and mixed business model (AUM-correlated wealth + cyclical Credit + lower-margin India workforce). 8.8x EV/EBITDA multiple may be partially justified by quality-of-growth (cyclical exposure) and quality-of-capital (acquired vs. organic). Re-rating to peer multiples not guaranteed even if growth holds.

“Central Street debate is binary: Is 47% drawdown a transient AI-narrative selloff that reverses on subscription-rate empirical proof, or permanent re-rating reflecting structurally lower growth and AI-driven margin pressure? Only 3 analysts cover MORN—institutional research infrastructure thin, amplifying both narratives. Bulls cite >100% renewal rates, $1.7B RPO, founder buybacks, SOP value. Bears cite PitchBook Q1'26 flat growth, DBRS cyclicality, ESG headwinds, lower-quality earnings mix. Q2 and Q3 2026 earnings prints are binary catalyst—if Direct/PitchBook renewal rates print >100% and DBRS sustains >15% organic, discount mechanically narrows; if either breaks, bear thesis crystallizes.”

• ◆Q2/Q3 2026 earnings—renewal rate proof (Direct ≥103%, Data ≥100%, PitchBook >3%; Direct/PitchBook organic re-acceleration)
• ◆Vanguard CRSP→Morningstar Indexes rebrand revenue ramp ($15–25M FY2027, multi-year high-margin royalty)
• ◆DBRS Credit structured-finance momentum continuation (+15%+ organic sustains; peak cycle risk)
• ◆Buyback program continuation at $300M+ annualized pace (founder capital-allocation signal)
• ◆AI-narrative reversal and multiple re-rating (8.8x→15x EV/EBITDA on proof thesis; >100% renewals hold)
• ◆DBRS intangible amortization roll-off (~$60M/year GAAP tailwind starting FY2028–2030)
• ◆PitchBook re-acceleration Q2–Q3 2026 (return to 5%+ organic after Q1 +0.1%)

• ◆AI disruption of data/analytics renewal rates: 35% 5-year probability, High impact, 7/10 severity; Mitigant: proprietary database moat, NRSRO regulatory protection, AI-as-customer thesis
• ◆FactSet/MSCI-Preqin competitive pricing pressure: 60% probability, Medium impact, 7/10 severity; Mitigant: multi-year RPO contracts delay switching, high switching costs
• ◆Structured-finance credit cycle downturn: 40% probability, Medium impact, 6/10 severity; Mitigant: fundamental ratings quality + European covered-bond franchise diversify
• ◆Mansueto founder departure/succession: 15% probability, Med-High impact, 5/10 severity; Mitigant: CEO Kapoor strong institutional successor, brand resilient post-founder
• ◆ESG mandate rollback (Sustainalytics revenue): 50%+ probability, Low-Med impact, 5/10 severity; Mitigant: EU SFDR still requires ESG data, US exposure ~$50M only
• ◆FX headwinds (USD strength vs. offshore revenue): 50% probability, Low-Med impact, 4/10 severity; Mitigant: India cost base creates natural hedge
• ◆Regulatory tightening on CRAs (NRSRO): 20% probability, Medium impact, 4/10 severity; Mitigant: NRSRO compliance costs already embedded, no enforcement activity disclosed